Stocktoria
Voyager Therapeutics, Inc. VYGR
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2015-11-11
Voyager Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 5,312,617 | $42.0M |
| MILLENNIUM MANAGEMENT LLC | 3,428,571 | $13.2M |
| TWO SIGMA INVESTMENTS, LP | 615,660 | $2.4M |
| RENAISSANCE TECHNOLOGIES LLC | 578,024 | $2.2M |
| CITADEL ADVISORS LLC | 402,764 | $1.6M |
| Point72 Asset Management, L.P. | 268,223 | $1.0M |
| AQR CAPITAL MANAGEMENT LLC | 232,681 | $898,149 |
| D. E. Shaw & Co., Inc. | 98,716 | $381,044 |
Source: SEC EDGAR filings · CIK 0001640266 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.